Added to YB: 2021-10-28
Pitch date: 2021-10-28
ADMA:US [bullish]
ADMA Biologics, Inc.
+705.56%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.
Market Cap
$2.3B
Pitch Price
$1.33
Price Target
N/A
Dividend
N/A
EV/EBITDA
10.37
P/E
14.54
EV/Sales
4.58
Sector
Biotechnology
Category
N/A
Show full summary:
ADMA Biologics, Inc. ADMA:US
A summary for this pitch has not been created yet.
Read full article (0 min)